Funding for this research was provided by:
national institute of allergy and infectious diseases
office of extramural research, national institutes of health (T32 GM007170)
Received: 27 July 2021
Accepted: 7 September 2021
First Online: 16 October 2021
: This study followed the principles of the Declaration of Helsinki, the International Conference on Harmonization (ICH)-Good Clinical Practice (GCP) guidelines, and the National Institute of Allergy and Infectious Diseases (NIAID) guidelines. This trial is registered at the US National Institutes of Health (ClinicalTrials.gov) #NCT02496676.
: All patients or their legal representatives provided written informed consent.
: Not applicable.
: The authors declare no competing interests.